NCT02695121View on ClinicalTrials.gov

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

CompletedOBSERVATIONAL

Enrollment

2,133,575

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions

Breast CancerBladder Cancer

Trial Locations (4)

Unknown

Research Site, Wilmington

Research Site, Washington D.C.

Research Site, Utrecht

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY